Levothyroxine Sodium Tablet
Product Images NDC 51655-583

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-583-52 (51655 583 52 Rev A 03 23)

NDC 51655-583-52 R0 Levothyroxine Sodium Tablets, USP 150 mcg (0.150 mg) per 30 Tablets are prescription-only drugs that must be stored at controlled room temperature between 15°C-30°C (59°F-86°F), protected from light and moisture, and kept away from children. For dosage information, refer to the package insert. The product has been repackaged by Northwind Pharmaceuticals from Lot 0000000000 of Lannett Company, Inc. The GTIN of the package is 00351655583524, and the serial number and expiry date are 000000000000000 and 00/00/0000, respectively.*

FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.